Hepatitis B reactivation during glioblastoma treatment with temozolomide: A cautionary note

被引：18

作者：

Chheda, M. G.

Drappatz, J.

Greenberger, N. J.

Kesari, S.

Weiss, S. E.

Gigas, D. C.

Doherty, L. M.

Wen, P. Y.

机构：

[1] Brigham & Womens Hosp, Div Canc Neurol, Dept Neurol, Boston, MA 02115 USA

[2] Brigham & Womens Hosp, Ctr Canc, Dana Farber Canc Inst, Ctr Neurooncol Oncol, Boston, MA 02115 USA

[3] Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA

[4] Harvard Univ, Sch Med, Boston, MA 02115 USA

来源：

NEUROLOGY | 2007年 / 68卷 / 12期

关键词：

D O I：

10.1212/01.wnl.0000259430.48835.b5

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：955 / 956

页数：2

共 10 条

[1] Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: Potential implications for future prophylaxis recommendations [J].

Law, JK ;

Ho, JK ;

Hoskins, PJ ;

Erb, SR ;

Steinbrecher, UP ;

Yoshida, EM .

LEUKEMIA & LYMPHOMA, 2005, 46 (07) :1085-1089

[2] Chronic hepatitis B: Update of recommendations [J].

Lok, ASF ;

McMahon, BJ .

HEPATOLOGY, 2004, 39 (03) :857-861

[3] Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma [J].

Stupp, R ;

Mason, WP ;

van den Bent, MJ ;

Weller, M ;

Fisher, B ;

Taphoorn, MJB ;

Belanger, K ;

Brandes, AA ;

Marosi, C ;

Bogdahn, U ;

Curschmann, J ;

Janzer, RC ;

Ludwin, SK ;

Gorlia, T ;

Allgeier, A ;

Lacombe, D ;

Cairncross, JG ;

Eisenhauer, E ;

Mirimanoff, RO ;

Van Den Weyngaert, D ;

Kaendler, S ;

Krauseneck, P ;

Vinolas, N ;

Villa, S ;

Wurm, RE ;

Maillot, MHB ;

Spagnolli, F ;

Kantor, G ;

Malhaire, JP ;

Renard, L ;

De Witte, O ;

Scandolaro, L ;

Vecht, CJ ;

Maingon, P ;

Lutterbach, J ;

Kobierska, A ;

Bolla, M ;

Souchon, R ;

Mitine, C ;

Tzuk-Shina, T ;

Kuten, A ;

Haferkamp, G ;

de Greve, J ;

Priou, F ;

Menten, J ;

Rutten, I ;

Clavere, P ;

Malmstrom, A ;

Jancar, B ;

Newlands, E .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (10) :987-996

[4] Prevention and control of hepatitis B in China [J].

Sun, ZT ;

Ming, LH ;

Zhu, X ;

Lu, JH .

JOURNAL OF MEDICAL VIROLOGY, 2002, 67 (03) :447-450

[5] Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy [J].

Yeo, W ;

Chan, PKS ;

Ho, WM ;

Zee, B ;

Lam, KC ;

Lei, KIK ;

Chan, ATC ;

Mok, TSK ;

Lee, JJ ;

Leung, TWT ;

Zhong, S ;

Johnson, PJ .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) :927-934

[6] Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy [J].

Yeo, W ;

Zee, B ;

Zhong, S ;

Chan, PKS ;

Wong, WL ;

Ho, WM ;

Lam, KC ;

Johnson, PJ .

BRITISH JOURNAL OF CANCER, 2004, 90 (07) :1306-1311

[7]

Yeo W, 2000, J MED VIROL, V62, P299, DOI 10.1002/1096-9071(200011)62:3&lt

[8]

299::AID-JMV1&gt

[9]

3.0.CO

[10]

2-0

← 1 →